Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Conjunctival Staining in Patients with Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and 3 Clinical Trials

Journal of Ocular Pharmacology and Therapeutics, Ahead of Print.

Source: Journal of Ocular Pharmacology and Therapeutics - August 1, 2019 Category: Opthalmology Authors: Robert Smyth-Medina Josh Johnston Douglas K. Devries April Jasper Shane R. Kannarr Barry A. Schechter Bridgitte Shen Lee George Varghese Abayomi Ogundele Charles H. Darby Paul Karpecki Jodi Luchs Source Type: research